IRBM is a contract research organization specializing in drug discovery and development services. The company offers a range of capabilities, including small molecule and peptide drug discovery, as well as antibody drug discovery. Its customers are primarily pharmaceutical and biotechnology companies seeking expertise to navigate the complexities of bringing new drugs to market.
2009
201–500